Skip to main content
Browse by:

Opportunities in Alzheimer's Disease Prevention: TOMMORROW - A Clinical Trial to Delay the Onset of Mild Cognitive Impairment

Kathleen Welsh-Bohmer, PhD, ABPP-cn
Thursday, February 27, 2020
12:00 pm - 1:00 pm
Kathleen Welsh-Bohmer, PhD, ABPP-cn
Psychiatry and Behavioral Sciences Grand Rounds

Sponsored by the Hans Lowenbach Memorial Fund. Dr. Kathleen Welsh-Bohmer is a Professor of Psychiatry and Neurology at Duke University. Clinically trained as a neuropsychologist, her research activities have been focused around developing effective prevention and treatment strategies to delay the onset of cognitive disorders occurring in later life. She was the Principal Investigator of the Cache County Memory Study (2002-2013), an epidemiological study of an exceptionally long- lived population that established key environmental modifiers affecting Alzheimer's disease onset and progression. Since 2006 she has directed the Joseph and Kathleen Bryan Alzheimer's Center at Duke University, where she has led a large multidisciplinary team focused around the genetic determinants of Alzheimer's disease and speeding drug discoveries to prevent and treat neurodegenerative diseases. She has served as the neuropsychology lead for the TOMMORROW program, a global clinical trial to delay the onset of mild cognitive impairment due to Alzheimer's disease. very recently, she was appointed to the Duke Clinical Research Institute (DCRI), an academic clinical research organization, to oversee its interventional trials within the Alzheimer's disease therapeutic area. Concurrently, she is leading science strategy for neurodegenerative disorders.

Contact: Angela Garrett